Literature DB >> 20516568

Infectivity and vaccination efficacy studies in animal models of HBV S and pol gene mutants.

Saleem Kamili1.   

Abstract

Infectious HBV wild-type and mutant clones were produced in vitro with three mutations in pol (rtV173L plus rtL180M plus rtM204V) or with a single mutation in the S gene (sG145R) and inoculated in treatment-naive chimpanzees. Intravenous inoculation of these mutants in chimpanzees resulted in HBV infection; the pol mutations remained stable, whereas the sG145R mutation reverted to wild type during viraemia. Additional hepatitis B vaccine efficacy studies conducted in chimpanzees showed lack of sterilizing immunity against the pol mutant. Whether such mutants can transmit to and infect vaccinated humans requires further investigation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20516568     DOI: 10.3851/IMP1520

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  4 in total

Review 1.  The chimpanzee model for hepatitis B virus infection.

Authors:  Stefan F Wieland
Journal:  Cold Spring Harb Perspect Med       Date:  2015-06-01       Impact factor: 6.915

Review 2.  Dendritic cells in hepatitis C infection: can they (help) win the battle?

Authors:  Angela Dolganiuc; Gyongyi Szabo
Journal:  J Gastroenterol       Date:  2011-02-17       Impact factor: 6.772

3.  A rare HBV subgenotype D4 with unique genomic signatures identified in north-eastern India--an emerging clinical challenge?

Authors:  Priyanka Banerjee; Rajiv Kumar Mondal; Madhuparna Nandi; Sumantra Ghosh; Mousumi Khatun; Nabendu Chakraborty; Swatilekha Bhattacharya; Arindam RoyChoudhury; Soma Banerjee; Amal Santra; Samir Sil; Abhijit Chowdhury; Pradip Bhaumik; Simanti Datta
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

4.  Recombinant HBsAg of the Wild-Type and the G145R Escape Mutant, included in the New Multivalent Vaccine against Hepatitis B Virus, Dramatically Differ in their Effects on Leukocytes from Healthy Donors In Vitro.

Authors:  Maria V Konopleva; Vera N Borisova; Maria V Sokolova; Tatyana A Semenenko; Anatoly P Suslov
Journal:  Vaccines (Basel)       Date:  2022-02-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.